Results 1 to 10 of about 18,575 (296)

Association between neuromuscular blocking agent use and outcomes among out-of-hospital cardiac arrest patients treated with extracorporeal cardiopulmonary resuscitation and target temperature management: A secondary analysis of the SAVE-J II study

Resuscitation Plus, 2023
Background: Neuromuscular blocking agents are used to control shivering in cardiac arrest patients treated with target temperature management. However, their effect on outcomes in patients treated with extracorporeal cardiopulmonary resuscitation is ...
Masatoshi Uchida, Migaku Kikuchi, Yasuo Haruyama, Toru Takiguchi, Toru Hifumi, Akihiko Inoue, Tetsuya Sakamoto, Yasuhiro Kuroda   +7 more
doaj   +2 more sources

Neuromuscular blocking agents in the intensive care unit [PDF]

Journal of International Medical Research, 2022
Neuromuscular blocking agents (NMBA) are a controversial therapeutic option in the approach to the critically ill patient. They are not innocuous, and the available evidence does not support their routine use in the intensive care unit.
Jonathan Rodríguez-Blanco, Tomás Rodríguez-Yanez, Jesús Daniel Rodríguez-Blanco, Amilkar José Almanza-Hurtado, María Cristina Martínez-Ávila, Diana Borré-Naranjo, María Camila Acuña Caballero, Carmelo Dueñas-Castell   +7 more
doaj   +2 more sources

Choice of neuromuscular block reversal agent to reduce postoperative pulmonary complications [PDF]

Anesthesia and Pain Medicine, 2022
The definition of postoperative pulmonary complications (PPCs) is inconsistent in literature; however, PPCs include pulmonary abnormalities that adversely affect patient outcomes, such as respiratory failure, atelectasis, pneumonia, pleural effusion, and
Sung-Ae Cho, Tae-Yun Sung
doaj   +3 more sources

Effectiveness of an educational module on nurses’ performance regarding safe administration and adverse effects of neuromuscular blocking agents in critically ill patients [PDF]

BMC Nursing
Background Inadequate nurse’s knowledge and poor skills regarding neuromuscular blocking agents lead to harm administration and associated with adverse effects and negative outcomes.
Shimaa Attia Ali, Enas Ebrahiem Elsayed, Ayman Muhammad Kamel Senosy   +2 more
doaj   +2 more sources

Newer Neuromuscular Blocking Agents [PDF]

Pharmacology & Toxicology, 1994
Four neuromuscular blocking drugs, doxacurium, mivacurium, pipecuronium, and rocuronium have been or are about to be introduced into clinical practice. The purpose of this MiniReview is to describe their pharmacology, to consider their place in clinical anaesthetic practice, and to examine whether the needs of the clinican have been met.
David R. Bevan
openaire   +3 more sources

REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study). [PDF]

J Clin Med, 2023
Greco M, Caruso PF, Angelotti G, Aceto R, Coppalini G, Martinetti N, Albini M, Bash LD, Carvello M, Piccioni F, Monzani R, Montorsi M, Cecconi M.   +12 more
europepmc   +3 more sources

Novel Insights on MRGPRX2-Mediated Hypersensitivity to Neuromuscular Blocking Agents And Fluoroquinolones. [PDF]

Front Immunol, 2021
Elst J, Maurer M, Sabato V, Faber MA, Bridts CH, Mertens C, Van Houdt M, Van Gasse AL, van der Poorten MM, De Puysseleyr LP, Hagendorens MM, Van Tendeloo VF, Lion E, Campillo-Davo D, Ebo DG.   +14 more
europepmc   +2 more sources

Trends in the use of neuromuscular blocking agents, reversal agents and neuromuscular transmission monitoring: a single-centre retrospective cohort study [PDF]

Perioperative Medicine
Background Residual neuromuscular blockade (rNMB) remains a persistent and preventable problem, with serious risks. Methods Our objective was to describe and assess patterns in the use of neuromuscular blocking agents (NMBAs), neuromuscular transmission (
Piet Krijtenburg, Arjen de Boer, Lori D. Bash, Gert Jan Scheffer, Christiaan Keijzer, Michiel C. Warlé   +5 more
doaj   +2 more sources

Association Between Intermediate-Acting Neuromuscular-Blocking Agents and Short-Term Postoperative Outcomes in Patients with Gastric Cancer [PDF]

Cancer Management and Research, 2020
Lingxia Niu,1,* Chunlin Yao,1,* Yu Wang,1 Yan Sun,1 Juan Xu,2 Yun Lin,1 Shanglong Yao1 1Department of Anesthesiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, Hubei, People’s Republic of ...
Niu L, Yao C, Wang Y, Sun Y, Xu J, Lin Y, Yao S   +6 more
doaj   +2 more sources

Reducing the dose of neuromuscular blocking agents with adjuncts: a systematic review and meta-analysis. [PDF]

Br J Anaesth, 2021
Weber V, Abbott TEF, Ackland GL.
europepmc   +3 more sources